- Home
- GPRE vs PRME Comparison
GPRE vs PRME Comparison
Compare GPRE & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPRE
- PRME
- Stock Information
- Founded
- GPRE 2004
- PRME 2019
- Country
- GPRE United States
- PRME United States
- Employees
- GPRE N/A
- PRME N/A
- Industry
- GPRE Major Chemicals
- PRME Medicinal Chemicals and Botanical Products
- Sector
- GPRE Industrials
- PRME Health Care
- Exchange
- GPRE Nasdaq
- PRME Nasdaq
- Market Cap
- GPRE 631.4M
- PRME 693.5M
- IPO Year
- GPRE N/A
- PRME 2022
- Fundamental
- Price
- GPRE $9.88
- PRME $4.01
- Analyst Decision
- GPRE Hold
- PRME Buy
- Analyst Count
- GPRE 7
- PRME 6
- Target Price
- GPRE $8.21
- PRME $8.88
- AVG Volume (30 Days)
- GPRE 2.1M
- PRME 2.8M
- Earning Date
- GPRE 10-30-2025
- PRME 11-11-2025
- Dividend Yield
- GPRE N/A
- PRME N/A
- EPS Growth
- GPRE N/A
- PRME N/A
- EPS
- GPRE N/A
- PRME N/A
- Revenue
- GPRE $2,397,101,000.00
- PRME $4,961,000.00
- Revenue This Year
- GPRE N/A
- PRME $179.58
- Revenue Next Year
- GPRE N/A
- PRME N/A
- P/E Ratio
- GPRE N/A
- PRME N/A
- Revenue Growth
- GPRE N/A
- PRME 739.42
- 52 Week Low
- GPRE $3.14
- PRME $1.11
- 52 Week High
- GPRE $14.04
- PRME $5.17
- Technical
- Relative Strength Index (RSI)
- GPRE 54.71
- PRME 57.38
- Support Level
- GPRE $9.50
- PRME $3.09
- Resistance Level
- GPRE $11.27
- PRME $4.18
- Average True Range (ATR)
- GPRE 0.57
- PRME 0.27
- MACD
- GPRE -0.16
- PRME 0.08
- Stochastic Oscillator
- GPRE 20.09
- PRME 77.31
About GPRE Green Plains Inc.
Green Plains Inc manufactures and sells ethanol and ethanol byproducts in two segments based on function. The ethanol production segment, which generates the majority of revenue, includes the production of ethanol, distillers grains, Ultra-High Protein and renewable corn oil. The agribusiness and energy services segment includes grain handling and storage, commodity marketing and merchant trading for company-produced and third-party ethanol, distillers grains, Ultra-High Protein, renewable corn oil, natural gas and other commodities.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.